Clinical trials
Completed Phase 2 Drug-Related Side Effects and Adverse Reactions trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Agency for Healthcare Research and Quality (AHRQ) | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Anhui Provincial Hospital | 1 |
| CSPC Ouyi Pharmaceutical Co., Ltd. | 1 |
| Chang Gung Memorial Hospital | 1 |
| Children's Hospital of Eastern Ontario | 1 |
| Children's Oncology Group | 1 |
| Harvard School of Public Health (HSPH) | 1 |
| Herbert Irving Comprehensive Cancer Center | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Drug-Related Side Effects and Adverse Reactions | 24 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Lung Neoplasms | 5 |
| Lymphoma | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Radiation Injuries | 3 |
| Adenocarcinoma of Lung | 2 |
| Anemia | 2 |
| Breast Neoplasms | 2 |
| Burkitt Lymphoma | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.